Carit Jacques Andersen

Carit Jacques Andersen has an extensive work experience in the finance industry. Carit Jacques started their career as an External Lecturer at the University of Southern Denmark in 1995 and later became an Examiner at the Copenhagen Business School in 2008. In 2006, they established their own consultancy firm called Decisionconsult A/S, where they worked as a Consultant and owner.

Throughout their career, Carit has held various leadership positions. Carit Jacques served as a Partner at ASNET from 2009 and as the Bestyrelsesformand (Chairman of the Board) at Scantron A/S from 2016. In 2017, they joined Scandion Oncology as the Chief Financial Officer until 2021.

Carit has also worked as an Interim Chief Financial Officer at Agillic from 2021 to 2022. Currently, they hold the position of Chief Financial Officer at Synklino since 2021 and Rehaler since 2022.

In 2019, Carit served as the Chief Financial Officer at 2cureX - Individualizing Cancer Treatment until 2021. Overall, Carit Jacques Andersen has a strong background in finance, with a focus on leadership roles in various companies and organizations.

Carit Jacques Andersen began their education at Midtfyns Gymnasium from 1980 to 1983. After completing high school, they enrolled at Syddansk Universitet - University of Southern Denmark, where they pursued a Master of Science in Business Administration from 1987 until 1992. Several years later, in 2013, Carit attended Aahus Universitet for a one-year program focused on board education with an emphasis on small and medium-sized businesses.